Hopital Robert Debré

Running trials

• Recruiting

  Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme

  NCT06475352· Phase 2· Source

• Recruiting

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· Phase 3· Source

• Active, not recruiting

  Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

  NCT04144387· Source

• Recruiting

  FARD (RaDiCo Cohort) (RaDiCo-FARD)

  NCT05954416· Source

• Active, not recruiting

  Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

  NCT03022188· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

  NCT05323591· Source

• Completed

  Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

  NCT03458260· Phase 2· Source

• Completed

  A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

  NCT03412773· Phase 3· Source

• Completed

  A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

  NCT02908672· Phase 3· Source

• Completed

  Lyme Borreliosis and Early Cutaneous Diagnostic

  NCT02414789· Source